@article{2984b61289754e64be1fa962f5782f4a,
title = "Duplications at 19q13.33 in patients with neurodevelopmental disorders",
author = "Eduardo P{\'e}rez-Palma and Elmo Saarentaus and Marie Ravoet and {De Ferrari}, {Giancarlo V.} and Peter N{\"u}rnberg and Bertrand Isidor and Neubauer, {Bernd A.} and Dennis Lal",
note = "Funding Information: The Article Processing Charge was funded by the authors. Funding Information: The authors thank all the clinicians, patients, and their families. This study makes use of data generated by the DECIPHER community. A full list of centers who contributed to the generation of the data is available from http://decipher.sanger.ac.uk and via email from decipher@ sanger.ac.uk. Funding for the project was provided by the Wellcome Trust. Funding Information: Eduardo P{\'e}rez-Palma was supported by the Chilean Fondo Nacional de Desarrollo Cient{\'i}fico y Tecnol{\'o}gico (FONDECYT) regular grant number 1140353 to Giancarlo V. De Ferrari. Dennis Lal received funds from the German Academic Exchange Service (DAAD), grant number 57073880. Bernd A. Neubauer received funding from the Deutsche For-schungsgemeinschaft (Ne 416/5-1). Funding Information: E. P{\'e}rez-Palma has received research support from Fondo Nacional de Ciencia y Tecnolog{\'i}a (FONDECYT), Chile. E. Saarentaus has received research support from the Institute for Molecular Medicine Finland (FIMM) and Sven-ska Studiefonden. M. Ravoet has been involved in clinical procedures/imaging studies at the Center of Human Genetics, Cliniques Universitaires St-Luc (10%), 2016. G.V. De Ferrari has received research support from Fondo Nacional de Ciencia y Tecnolog{\'i}a (FONDECYT), Chile, and CON-ICYT. Chile. P. Nuernberg is a founder, CEO, and shareholder of ATLAS Biolabs GmbH (ATLAS Biolabs GmbH is a service provider for genomic analyses). B. Isidor reports no disclosures. B. Neubauer has served on the scientificadvisory boards of and has received travel funding/speaker honoraria from Eisai, Bial, and UCB Pharma; has served on the editorial board of Neuropediatrics; and has received research support from DFG 416/5-1 (German national funding agency). D. Lal reports no disclosures. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.",
year = "2018",
month = feb,
day = "1",
doi = "10.1212/NXG.0000000000000210",
language = "English",
volume = "4",
journal = "NEUROLOGY-GENETICS",
issn = "2376-7839",
publisher = "Lippincott Williams and Wilkins",
number = "1",
}